Skip to main content
Premium Trial:

Request an Annual Quote

InforMax Promotes Stephen Lincoln To Chief Scientific Officer

NEW YORK, May 1 – InforMax has promoted Stephen Lincoln to executive vice president, product development and chief scientific officer, the company said Tuesday.

Concurrent with Lincoln’s promotion, InforMax said that Vadim Babenko, the company’s chief technology officer, would step down and instead provide advisory services for the company.

Lincoln joined the company in December  2000 as senior vice president of life science informatics. Prior to joining InforMax, he served as president of bioinformatics research and development at Incyte Genomics.

"With Steve's broader responsibilities, he will play an even greater role in spearheading our product development efforts in building the current and next generation versions of InforMax's product line, said Alex Titomirov, CEO of Informax, in a statement. “In addition, Steve will be interfacing with InforMax customers and alliance partners on developing and implementing discovery research strategies, expanding the value and role of products and services that the company provides to our customers."
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.